Risperidone Leads to Serious Metabolic Problems in Autistic Children
The Carlat Child Psychiatry Report, Volume 7, Number 4, May 2016
https://www.thecarlatreport.com/newsletter-issue/ccprv7n4/
Issue Links: Learning Objectives | Editorial Information
Topics: Autism Spectrum Disorder | Child Psychiatry | Research Updates
Bret A. Moore, PsyD, ABPP
The metabolic effects of atypical antipsychotics in children are well known, and carefully weighing the risk-benefit ratio of their use is a difficult ordeal for both parents and clinicians. The reality is that the use of these meds is necessary for some children, particularly those dealing with an autism spectrum disorder with serious behavioral problems.
You can't view details of this content, please login or buy subscription here
Bret A. Moore, PsyD, ABPP
Board-Certified Clinical Psychologist, San Antonio, TX
Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.